Fundraising Fox
/Companies
Sign in

TippingPoint Biosciences

San Francisco, US · Founded 2022 · 8 employees on LinkedIn · 15 known investors

Find your way into TippingPoint Biosciences

Sign up to see every warm intro you have to TippingPoint Biosciences

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the TippingPoint Biosciences team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

TippingPoint Biosciences is a therapeutics company developing a drug discovery platform that targets unstructured regions in chromatin proteins to treat diseases caused by dysfunctional genome chromatin packaging, with a focus on cancer. Its approach aims to increase specificity, reduce toxicity, and limit drug resistance in oncology treatments.

BiotechDeep TechHealthtech

Founders & leadership

TippingPoint Biosciences was founded in 2022 by Laura Hsieh.

LHLaura Hsieh
Laura HsiehFounder & CEOLaura Hsieh holds a Ph.D. in Molecular and Cellular Biology from the University of Washington/Fred Hutchinson Cancer Research Center and conducted postdoctoral research at UCSF; she is the founder and CEO of TippingPoint Biosciences, which develops a chromatin-targeting drug discovery platform for oncology.

Investors · 15

SOSVlisted by SOSVNew York · $30K – $550K

How we know: finance.yahoo.com · funding news · open dataset · 5k.vc investor directory · sosv.com · Not right? Tell us

BrightEdgereportedAtlanta

How we know: prnewswire.com · open dataset · investor-profiles · Not right? Tell us

Empath VenturesreportedSan Francisco

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

SazzereportedBurlingame

How we know: finance.yahoo.com · funding news · Not right? Tell us

StoryHousereportedSisters

How we know: finance.yahoo.com · funding news · Not right? Tell us

XEIA Venture PartnersreportedSan Francisco

How we know: finance.yahoo.com · Not right? Tell us

Also in the syndicate · 8

American Cancer Society BrightEdgeFreeflow VenturesLKS FundleadPediatric Brain Tumor FoundationSontag FoundationSontag Innovation FundWeCANYuvaan Tiwari Foundation

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

TippingPoint Biosciences Secures $4.5 | Signalbasetrysignalbase.com · Apr 2026TippingPoint Biosciences Raises $4.5M in Seed Fundingfinsmes.com · Apr 2026TippingPoint Biosciences Raises $4.5M Seed to Drug Hidden Epigenetic Targets in Deadly Pediatric Brain Cancerfinance.yahoo.com · Mar 2026TippingPoint Biosciences Closes New Funding to Support Drug for Rare Pediatric Brain Tumorprnewswire.com · Sep 2024

Frequently asked questions

What does TippingPoint Biosciences do?
TippingPoint Biosciences is a therapeutics company developing a drug discovery platform that targets unstructured regions in chromatin proteins to treat diseases caused by dysfunctional genome chromatin packaging, with a focus on cancer. Its approach aims to increase specificity, reduce toxicity, and limit drug resistance in oncology treatments.
Who founded TippingPoint Biosciences?
TippingPoint Biosciences was founded by Laura Hsieh in 2022.
Who are TippingPoint Biosciences's investors?
TippingPoint Biosciences's investors include FREEFLOW, SOSV, BrightEdge, Empath Ventures, Sazze, StoryHouse, XEIA Venture Partners.
Where is TippingPoint Biosciences headquartered?
TippingPoint Biosciences is headquartered in San Francisco, US.